ecancer
ecancer is a UK charity which provides accessible, high-quality educational content, free to the global oncology community. Our mission is to raise the standards of care for cancer patients across the world through education.
Primary Results of the Phase III SHINE Study: Ibrutinib in Combination With Bendamustine, Rituximab & Rituximab Maintenance as 1L Therapy for Older Patients With Mantle Cell Lymphoma
By
ecancer
FEATURING
Michael Wang
By
ecancer
FEATURING
Michael Wang
This video was recorded prior to FDA approval of Pirtobrutinib on January 26, 2023 in ...
read more ↘
read more ↘
Login to view comments.
Click here to Login
